Skip to main content
OpenTrials

Clinical trial condition

Liver Cirrhosis

Explore clinical trials studying Liver Cirrhosis. Study availability and eligibility vary by location and protocol.

167 public trials 37 recruiting studies
Refine in advanced search Browse all conditions

Liver Cirrhosis trial results

Completed

Pegfilgrastim in Patients With Alcoholic Hepatitis

NCT02776059

Conditions
Alcohol-Induced Disorders, Alcohol-Related Disorders, Alcoholic Hepatitis, +12 more
Locations
  • VA Loma Linda Healthcare System Loma Linda, California, United States
  • VA Long Beach Healthcare System Long Beach, California, United States
  • LAC-USC Medical Center Los Angeles, California, United States
  • Harbor-UCLA Medical Center Torrance, California, United States
View Trial Details
Completed

Study of INT-747 as Monotherapy in Participants With Primary Biliary Cirrhosis (PBC)

NCT00570765

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +8 more
Locations
  • Henry Ford Detroit, Michigan, United States
  • Baylor College of Medicine Houston, Texas, United States
  • Virginia Commonwealth University Richmond, Virginia, United States
  • Virginia Mason Medical Center Seattle, Washington, United States
View all 21 locations
View Trial Details
Completed

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Primary Biliary Cholangitis

NCT03394924

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • Digestive Health Specialists of the Southeast Dothan, Alabama, United States
  • Arkansas Diagnostic Center Little Rock, Arkansas, United States
  • Texas Clinical Research Institute Little Rock, Arkansas, United States
  • Southern California Research Center Coronado, California, United States
View all 86 locations
View Trial Details
Completed

Phase 3 Study of Obeticholic Acid in Patients With Primary Biliary Cirrhosis

NCT01473524

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • UC Davis Medical Center Sacramento, California, United States
  • Scripps Clinic San Diego, California, United States
  • University of Colorado, Denver Aurora, Colorado, United States
  • University of Chicago Chicago, Illinois, United States
View all 59 locations
View Trial Details
Completed

Dose Response Study of GSK2330672 for the Treatment of Pruritus in Participants With Primary Biliary Cholangitis

NCT02966834

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +13 more
Locations
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Sacramento, California, United States
  • GSK Investigational Site Miami, Florida, United States
  • GSK Investigational Site Novi, Michigan, United States
View all 66 locations
View Trial Details
Completed

A Multi-part, Double Blind Study to Assess Safety, Tolerability and Efficacy of Tropifexor (LJN452) in PBC Patients

NCT02516605

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • Novartis Investigative Site Rialto, California, United States
  • Novartis Investigative Site Miami, Florida, United States
  • Novartis Investigative Site Atlanta, Georgia, United States
  • Novartis Investigative Site Marietta, Georgia, United States
View all 28 locations
View Trial Details

Related conditions